Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 2 boards, counting each seat separately. Longest: Xilio Therapeutics Inc., 3 years.
Xilio Therapeutics Inc.
Director
Latigo Biotherapeutics Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 3, 2026 | Insmed Incorporated | Open-market sale | −2,404 | $102.27 | $245,857 |
| May 13, 2026 | Insmed Incorporated | Open-market sale | −8,272 | $116.18 | $961,041 |
| Feb 3, 2026 | Insmed Incorporated | Open-market sale | −748 | $156.34 | $116,942 |
| Jan 8, 2026 | Insmed Incorporated | Open-market sale | −1,447 | $174.17 | $252,024 |
| Jan 7, 2026 | Insmed Incorporated | Open-market sale | −1,678 | $175.07 | $293,767 |
| Jan 6, 2026 | Insmed Incorporated | Open-market sale | −1,517 | $173.33 | $262,942 |
| Jan 2, 2026 | Insmed Incorporated | Grant or award | +5,998 | — | — |
| Jan 2, 2026 | Insmed Incorporated | Grant or award | +5,645 | — | — |
| Jul 21, 2025 | Insmed Incorporated | Option exercise | +3,443 | $26.46 | $91,102 |
| Jul 21, 2025 | Insmed Incorporated | Option exercise | +11,455 | $28.88 | $330,820 |
| Jul 21, 2025 | Insmed Incorporated | Option exercise | +15,890 | $29.13 | $462,876 |
| Jul 21, 2025 | Insmed Incorporated | Option exercise | +17,100 | $34.03 | $581,913 |
| Jul 21, 2025 | Insmed Incorporated | Open-market sale | −32,090 | $102.38 | $3,285,374 |
| Jul 21, 2025 | Insmed Incorporated | Open-market sale | −26,310 | $103.03 | $2,710,719 |
| Jul 7, 2025 | Insmed Incorporated | Option exercise | +6,244 | $19.74 | $123,257 |
Questions about Sara Bonstein
What boards is Sara Bonstein on?
Sara Bonstein sits on the boards of Latigo Biotherapeutics Inc. and Xilio Therapeutics Inc.
How long has Sara Bonstein served on boards?
Our records show at least 4 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.